Skip to content
drillr.ai
Sign up

CYCN

Cyclerion Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$4.25
−14.31%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue1.9M2.1M2.0M—297.0K
Cost of Revenue730.0K——1.3M5.6M
Gross Profit1.2M2.1M2.0M(1.3M)(5.3M)
Operating Expenses
R&D Expense1.6M959.0K286.0K1.5M6.0M
SG&A Expense7.1M6.1M5.3M8.3M13.3M
General & Admin Expense7.1M6.1M5.3M8.1M12.9M
Selling & Marketing Expense———200.0K400.0K
Other Expenses(730.0K)——1.8M(6.0M)
Total Operating Expenses8.0M7.0M5.6M11.6M13.3M
Cost and Expenses8.7M7.0M5.6M13.0M18.8M
Operating Income (EBIT)(6.8M)(5.0M)(3.6M)(13.0M)(18.5M)
Non-Operating
Interest Income117.0K128.0K208.0K358.0K294.0K
Interest Expense—————
Net Interest Income117.0K128.0K208.0K358.0K294.0K
Other Non-Op Income/Expense117.0K1.4M571.0K358.0K294.0K
Non-Operating Income (excl Interest)(117.0K)(1.4M)(571.0K)(3.3M)(294.0K)
EBT (Pre-Tax Income)(6.7M)(3.5M)(3.1M)(12.6M)(18.2M)
Income Tax Expense—————
Bottom Line
Net Income(6.7M)(3.5M)(3.1M)(5.3M)(44.1M)
Earnings from Cont. Ops(6.7M)(3.5M)(3.1M)(12.6M)(18.2M)
Earnings from Discont. Ops———7.3M(25.8M)
Bottom Line Net Income(6.7M)(3.5M)(3.1M)(12.6M)(18.2M)
Per Share
Basic EPS($1.72)($1.09)($1.21)($8.99)($20.15)
Diluted EPS($1.72)($1.09)($1.21)($8.99)($20.15)
Revenue Per Share$0.45$0.64$0.79$0.00$0.14
Shares
Basic Shares Outstanding4.3M3.2M2.5M2.3M2.2M
Diluted Shares Outstanding4.3M3.2M2.5M2.3M2.2M
Profitability Metrics
EBITDA(6.7M)(3.5M)(3.1M)(9.6M)(18.2M)
D&A———65.0K65.0K
EBIT(6.7M)(3.5M)(3.1M)(9.6M)(18.2M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026